Fast Market Research announces the availability of the new TechNavio report, "Global Diabetic Therapeutic Market 2017-2021", on their comprehensive research portal

Boston, MA -- (SBWire) -- 03/23/2017 --The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than 1.5 million deaths occur due to diabetes worldwide each year.

Technavio's analysts forecast the global diabetic therapeutic market to grow at a CAGR of 7.55% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global diabetic therapeutic market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded drugs, generics, and biosimilars used for the treatment of diabetes. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period..

Get More Details on this Report and a Full Table of Contents at Global Diabetic Therapeutic Market 2017-2021

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Diabetic Therapeutic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-AstraZeneca
-Eli Lilly
-Merck
-Novo Nordisk
-Sanofi

Other prominent vendors

-AbbVie
-Actelion Pharmaceuticals
-Adocia
-Aegerion Pharmaceuticals
-Akros Pharma
-Alnylam Pharmaceuticals
-Amarin
-Amgen
-Amicus Therapeutics
-Arbutus Biopharma
-Arena Pharmaceuticals
-Astellas Pharma
-Atheronova
-Aurobindo Pharma
-Baxalta
-Belrose Pharma
-BHV Pharma
-Biocon
-Biodel
-BioMarin
-Bionaturis
-Biosidus
-Biospherics
-Boehringer Ingelheim
-Bristol-Myers Squibb
-Catabasis Pharmaceuticals
-Cerenis Therapeutics
-Chipscreen Biosciences
-Cipla
-CJ HealthCare
-CKD Bio
-Concord Biotech
-ConjuChem
-CureDM
-CymaBay Therapeutics
-Daewoong
-Daiichi Sankyo
-Dance Biopharm
-DiaMedica
-Diamyd Therapeutics
-Diasome Pharmaceuticals
-DiaVacs
-Dong-A ST
-Eisai
-Elcelyx Therapeutics
-Esperion Therapeutics
-Exsulin
-F. Hoffmann-La Roche
-Gan & Lee Pharmaceuticals
-Generex Biotechnology
-Genfit
-GlaxoSmithKline
-HanAll BioPharma
-Hanmi Pharmaceutical
-Hua Medicine
-Iltoo Pharma
-Intarcia Therapeutics
-InteKrin Therapeutics
-Intrexon
-Ionis Pharmaceuticals
-Islet Sciences
-ISU Abxis
-Janssen Pharmaceuticals
-Japan Tobacco
-JCR Pharmaceuticals
-JW Pharmaceuticals
-Kadmon Pharmaceuticals
-Kamada
-KinDex Pharmaceuticals
-Kissei
-Kotobuki
-Kowa Company
-Laboratoires SMB
-Lexicon Pharmaceuticals
-Ligand Pharmaceuticals
-Living Cell Technologies
-Livzon
-LIXTE Biotechnology
-Lupin
-MacroGenics
-Madrigal Pharmaceuticals
-MannKind Corporation
-MedImmune
-Melior Pharmaceuticals
-Merrion Pharmaceuticals
-Merz Pharmaceuticals
-Metabolic Solutions Development
-Mitsubishi Tanabe Pharma
-Mylan
-Neothetics
-Neuraltus Pharmaceuticals
-NGM Biopharmaceuticals
-Norgine
-Novartis
-NuSirt Biopharma
-Oramed
-Orexigen Therapeutics
-Osiris Therapeutics
-Peptron
-Perle Biosciences
-Pfizer
-PhaseBio Pharmaceuticals
-Poxel
-Protalix BioTherapeutics
-Raptor
-Recordati
-Regeneron Pharmaceuticals
-REGENX BioSciences
-REGiMMUNE
-Rhythm Pharmaceuticals
-Saniona
-Santaris Pharma
-Sanwa Kagaku Kenkyusho
-Serometrix
-Shionogi
-Shire
-Sigma-Tau
-Sirona Biochem
-Strongbridge Biopharma
-Sun Pharma
-Takeda Pharmaceuticals
-Teva
-Thera Technologies
-Theracos
-Toleranzia
-Tolerion
-Torrent Pharmaceuticals
-Transition Therapeutics
-UCB
-Utrecht Holdings
-VeroScience
-Vivus
-vTv Therapeutics
-XBiotech
-Xeris Pharmaceuticals
-XOMA
-Zafgen
-Zydus Cadila

Companies Mentioned in this Report: AstraZeneca, Eli Lilly, Merck, Novo Nordisk, Sanofi, AbbVie, Actelion Pharmaceuticals, Adocia, Aegerion Pharmaceuticals, Akros Pharma, Alnylam Pharmaceuticals, Amarin, Amgen, Amicus Therapeutics, Arbutus Biopharma, Arena Pharmaceuticals, Astellas Pharma, Atheronova, Aurobindo Pharma, Baxalta, Belrose Pharma, BHV Pharma, Biocon, Biodel, BioMarin, Bionaturis, Biosidus, Biospherics, Boehringer Ingelheim, Bristol-Myers Squibb, Catabasis Pharmaceuticals, Cerenis Therapeutics, Chipscreen Biosciences, Cipla, CJ HealthCare, CKD Bio, Concord Biotech, ConjuChem, CureDM, CymaBay Therapeutics, Daewoong, Daiichi Sankyo, Dance Biopharm, DiaMedica, Diamyd Therapeutics, Diasome Pharmaceuticals, DiaVacs, Dong-A ST, Eisai, Elcelyx Therapeutics, Esperion Therapeutics, Exsulin, F. Hoffmann-La Roche, Gan & Lee Pharmaceuticals, Generex Biotechnology, Genfit, GlaxoSmithKline, HanAll BioPharma, Hanmi Pharmaceutical, Hua Medicine, Iltoo Pharma, Intarcia Therapeutics, InteKrin Therapeutics, Intrexon, Ionis Pharmaceuticals, Islet Sciences, ISU Abxis, Janssen Pharmaceuticals, Japan Tobacco, JCR Pharmaceuticals, JW Pharmaceuticals, Kadmon Pharmaceuticals, Kamada, KinDex Pharmaceuticals, Kissei, Kotobuki, Kowa Company, Laboratoires SMB, Lexicon Pharmaceuticals, Ligand Pharmaceuticals, Living Cell Technologies, Livzon, LIXTE Biotechnology, Lupin, MacroGenics, Madrigal Pharmaceuticals, MannKind Corporation, MedImmune, Melior Pharmaceuticals, Merrion Pharmaceuticals, Merz Pharmaceuticals, Metabolic Solutions Development, Mitsubishi Tanabe Pharma, Mylan, Neothetics, Neuraltus Pharmaceuticals, NGM Biopharmaceuticals, Norgine, Novartis, NuSirt Biopharma, Oramed, Orexigen Therapeutics, Osiris Therapeutics, Peptron, Perle Biosciences, Pfizer, PhaseBio Pharmaceuticals, Poxel, Protalix BioTherapeutics, Raptor, Recordati, Regeneron Pharmaceuticals, REGENX BioSciences, REGiMMUNE, Rhythm Pharmaceuticals, Saniona, Santaris Pharma, Sanwa Kagaku Kenkyusho, Serometrix, Shionogi, Shire, Sigma-Tau, Sirona Biochem, Strongbridge Biopharma, Sun Pharma, Takeda Pharmaceuticals, Teva, Thera Technologies, Theracos, Toleranzia, Tolerion, Torrent Pharmaceuticals, Transition Therapeutics, UCB, Utrecht Holdings, VeroScience, Vivus, vTv Therapeutics, XBiotech, Xeris Pharmaceuticals, XOMA, Zafgen, Zydus Cadila

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2016
-Diabetic Macular Edema Global Clinical Trials Review, H1, 2016
-Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2016
-Diabetic Retinopathy Global Clinical Trials Review, H1, 2016
-Diabetic Foot Ulcers Global Clinical Trials Review, H1, 2016